MediWound (MDWD) News Today → get a piece of the profit from this land (From True Market Insiders) (Ad) Free MDWD Stock Alerts $16.98 -0.31 (-1.79%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13, 2024 | finance.yahoo.comInvestors in MediWound (NASDAQ:MDWD) have seen decent returns of 65% over the past yearMay 9, 2024 | americanbankingnews.comMediWound (NASDAQ:MDWD) Upgraded to "Sell" by StockNews.comMay 9, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Upgraded to Sell by StockNews.comStockNews.com upgraded shares of MediWound to a "sell" rating in a research note on Wednesday.April 30, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Upgraded to Sell at StockNews.comStockNews.com upgraded shares of MediWound to a "sell" rating in a report on Tuesday.April 25, 2024 | globenewswire.comMediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care ConferencesApril 17, 2024 | finance.yahoo.comStrength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?March 27, 2024 | marketbeat.comSilverberg Bernstein Capital Management LLC Invests $803,000 in MediWound Ltd. (NASDAQ:MDWD)Silverberg Bernstein Capital Management LLC purchased a new stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 78,984 shares of the biopharmaceutical company'sMarch 24, 2024 | finance.yahoo.comMediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?March 23, 2024 | seekingalpha.comMediWound Ltd. (MDWD) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | marketbeat.comStockNews.com Upgrades MediWound (NASDAQ:MDWD) to "Hold"StockNews.com upgraded shares of MediWound from a "sell" rating to a "hold" rating in a research report on Friday.March 22, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $28.00 price target on shares of MediWound in a report on Friday.March 21, 2024 | markets.businessinsider.comMediwound Poised for Growth: A Strong Buy Recommendation Amidst Promising Prospects and Strategic ExpansionMarch 21, 2024 | investorplace.comMDWD Stock Earnings: MediWound Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | msn.comMediWound reports mixed Q4 results; initiates FY24 outlookMarch 21, 2024 | chron.comMediWound: Q4 Earnings SnapshotMarch 21, 2024 | globenewswire.comMediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateMarch 20, 2024 | msn.comMediWound Q4 2023 Earnings PreviewMarch 15, 2024 | marketbeat.comMediWound (MDWD) Scheduled to Post Quarterly Earnings on ThursdayMediWound (NASDAQ:MDWD) will be releasing earnings before the market opens on Thursday, March 21, Zacks reports.March 14, 2024 | globenewswire.comMediWound to Report Fourth Quarter and Full Year 2023 Financial ResultsMarch 7, 2024 | finance.yahoo.comRetail investors who hold 38% of MediWound Ltd. (NASDAQ:MDWD) gained 15%, institutions profited as wellFebruary 23, 2024 | msn.comNexobrid: A revolutionary treatment for burns to treat patients in few hoursFebruary 12, 2024 | marketwatch.comMediWound Shares Climb on Positive Data for EscharExFebruary 12, 2024 | markets.businessinsider.comMediWound Reports Positive Results In Head-to-head Comparison Of EscharEx Vs SANTYLFebruary 12, 2024 | finance.yahoo.comMediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled StudyFebruary 5, 2024 | finance.yahoo.comMediWound to Participate in Two Upcoming Investor ConferencesJanuary 18, 2024 | marketbeat.comHC Wainwright Brokers Cut Earnings Estimates for MediWound Ltd. (NASDAQ:MDWD)MediWound Ltd. (NASDAQ:MDWD - Free Report) - Research analysts at HC Wainwright lowered their FY2023 EPS estimates for MediWound in a report released on Tuesday, January 16th. HC Wainwright analyst S. Ramakanth now expects that the biopharmaceutical company will earn ($0.53) per share for the yeaJanuary 16, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Price Target Raised to $28.00HC Wainwright increased their price objective on shares of MediWound from $26.00 to $28.00 and gave the company a "buy" rating in a research note on Tuesday.January 16, 2024 | marketbeat.comStockNews.com Lowers MediWound (NASDAQ:MDWD) to SellStockNews.com lowered shares of MediWound from a "hold" rating to a "sell" rating in a research report on Tuesday.January 15, 2024 | finance.yahoo.comMediWound (MDWD)'s Technical Outlook is Bright After Key Golden CrossJanuary 13, 2024 | marketbeat.comYelin Lapidot Holdings Management Ltd. Takes $917,000 Position in MediWound Ltd. (NASDAQ:MDWD)Yelin Lapidot Holdings Management Ltd. acquired a new stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 86,145 shares of the bioJanuary 12, 2024 | markets.businessinsider.comMediwound Poised for Growth: Buy Rating Affirmed Amidst FDA Progress, Revenue Forecasts, and Expansion PotentialJanuary 9, 2024 | finance.yahoo.comWall Street Analysts Think MediWound (MDWD) Could Surge 134.77%: Read This Before Placing a BetJanuary 9, 2024 | markets.businessinsider.comMediWound: FDA To Review NexoBrid SBLA For Removal Of Eschar In Pediatric PatientsJanuary 9, 2024 | msn.comFDA accepts MediWound application for NexoBrid pediatric approvalJanuary 9, 2024 | finance.yahoo.comMediWound (MDWD): Strong Industry, Solid Earnings Estimate RevisionsJanuary 9, 2024 | finance.yahoo.comMediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal BurnsDecember 28, 2023 | markets.businessinsider.comMediWound Secures $6.7 Mln From US Department Of Defense For NexoBrid In Field-Care Burn TreatmentDecember 21, 2023 | finance.yahoo.comMediWound Announces Peer-Reviewed Publication of EscharEx® Mechanism of Action Study Assessing Its Effects on Biofilm and Microbial LoadsDecember 18, 2023 | finance.yahoo.comMediWound Ltd. (NASDAQ:MDWD) Stock Rockets 26% As Investors Are Less Pessimistic Than ExpectedDecember 13, 2023 | finance.yahoo.comWall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to TradeDecember 5, 2023 | finance.yahoo.comMediWound (NASDAQ:MDWD) investors are sitting on a loss of 75% if they invested five years agoNovember 27, 2023 | finance.yahoo.comDoes MediWound (MDWD) Have the Potential to Rally 223.05% as Wall Street Analysts Expect?November 24, 2023 | markets.businessinsider.comMediwound’s Promising Outlook: Buy Rating Justified by Q3 Results and Expanding Market OpportunitiesNovember 22, 2023 | markets.businessinsider.comStrong Buy Recommendation for Mediwound: Imminent Drivers, Promising Revenue Stream and Solid Financial FootingNovember 21, 2023 | benzinga.comRecap: MediWound Q3 EarningsNovember 21, 2023 | finance.yahoo.comMediWound Reports Third Quarter 2023 Financial Results and Provides Company UpdateNovember 20, 2023 | msn.comMediWound Q3 2023 Earnings PreviewNovember 14, 2023 | finance.yahoo.comMediWound to Report Third Quarter 2023 Financial ResultsNovember 13, 2023 | marketwatch.comMediWound Gets CHMP Positive Opinion for NexoBridNovember 13, 2023 | finanznachrichten.deMediWound Ltd.: MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid to Treat Pediatric Patients Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land. Click here to see my #1 investment for 2024. MDWD Media Mentions By Week MDWD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDWD News Sentiment▼1.190.42▲Average Medical News Sentiment MDWD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDWD Articles This Week▼11▲MDWD Articles Average Week Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FitLife Brands News ChromaDex News Natural Alternatives International News Mannatech News Aurora Cannabis News biote News Mind Medicine (MindMed) News Inventiva News Orchestra BioMed News Biodesix News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDWD) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
